← Eichor
Study identifier: NCT06928337 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality.

Condition: Fertility Disorders  ·  Sponsor: Fairtility

PhaseN/A
Planned participants350
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersYes

About this study

This data collection protocol is aimed to allow the reliable and robust development (training, verification, and validations) of CHLOE technology-based applications as well as improve the machine learning stage of released devices/applications. Additionally, a simulated use assessments will be conducted to ensure the correct and easy use of the CHLOE applications.

This description comes directly from the study's public registry record.

Talk to the study team

Pedro Pini, M.D  ·  +54 9 1144704026  ·  pedro.pini@fairtility.com

Always discuss trial participation with your own doctor first.

Locations (1)

The World Egg and Sperm BankScottsdale, Arizona, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06928337